10.24 USD
-0.45 (-4.21%)
10.24 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to CRBP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 43.18. This target is 321.68% above the current price.
CRBP was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CRBP.
In the previous month the buy percentage consensus was at a similar level.
CRBP was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | Jefferies | Maintains | Buy -> Buy |
| 2025-02-28 | William Blair | Initiate | Outperform |
| 2025-02-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-02 | Piper Sandler | Initiate | Overweight |
| 2024-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | Mizuho | Reiterate | Outperform -> Outperform |
| 2024-09-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-20 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-09-20 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-08-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2024-07-10 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-06-26 | B. Riley Securities | Initiate | Buy |
| 2024-06-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-06-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-13 | RBC Capital | Initiate | Outperform |
| 2024-05-08 | Oppenheimer | Maintains | Outperform -> Outperform |
CORBUS PHARMACEUTICALS HOLDI / CRBP FAQ
What is the average price target for CORBUS PHARMACEUTICALS HOLDI (CRBP) stock?
16 analysts have analysed CRBP and the average price target is 43.18 USD. This implies a price increase of 321.68% is expected in the next year compared to the current price of 10.24.
What is the consensus rating for CRBP stock?
The consensus rating for CORBUS PHARMACEUTICALS HOLDI (CRBP) is 86.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for CRBP stock?
The number of analysts covering CORBUS PHARMACEUTICALS HOLDI (CRBP) is 16.